Overview

Zaleplon in HIV Patients With Depression

Status:
Completed

Trial end date:
2015-02-04

Target enrollment:

Participant gender:

Summary

In HIV positive patients with sleep onset insomnia and receiving pharmacologic treatment for comorbid depression, the proposed study aims to evaluate the impact of zaleplon on sleep measures determined by insomnia severity index (ISI) and Epworth sleepiness scale (ESS).

Phase:

Phase 2

Details

Lead Sponsor:

University of Pennsylvania

Treatments:

Zaleplon